Overall rank by patents
#47,955
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Jiangsu ranks #47,955 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R47955 · Foreign Corporation #47,955 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Jiangsu Oppeal Daily Cosmetics Corp., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Jiangsu Vcare… · this assignee
39 score
3D Lighting… · lowest
7 score
What this shows Jiangsu's Innovation Score is 38.9/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Jiangsu Vcare Pharmatech Co., Ltd. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). By volume, Jiangsu sits between Jiangsu Oppeal Daily Cosmetics Corp., Ltd. and Jilin Oled Material Tech. Co., Ltd..
Jiangsu Vcare Pharmatech Co., Ltd. shows 3 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Jiangsu Oppeal Daily Cosmetics Corp., Ltd.
5 patents
Jiangsu Riyu Photovoltaic NEW Material Technology Co. Ltd
5 patents
Jiangsu Sainty Sumex Tools Corp. Ltd.
5 patents
Jiangsu Tongrun Equipment Technology Co., Ltd.
5 patents
Jiangxi Jemincare Group Co., Ltd
5 patents
Jiangyin Sian Plastic Protech Co.
5 patents
Jietai Purification Tech Co., Ltd.
5 patents
Jilin Oled Material Tech. Co., Ltd.
5 patents
Jiangsu Vcare Pharmatech Co., Ltd.
5 patents
What this shows Jiangsu holds 5 patents at rank #47,939, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #47,939 in granted patent volume.
Other assignees with the most granted patents in Jiangsu's primary technology class.
Jiangsu's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
39 Top 40% higher than 60% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 20.0% |
| 2022 | 1 | 20.0% |
| 2023 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
| 2025partial year | 1 | 20.0% |
Top 4 of 4 technology areas
Overall rank by patents
#47,955
of 49,997 tracked assignees
38.9 out of 100
What to do with this data
Jiangsu Vcare Pharmatech Co., Ltd.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.